http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 08 Sep 2026 05:39:33 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Intl+Ratings/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Raised+to+EUR240+at+Barclays/27032457.html Barclays analyst Charles Pitman raised the price target on Sartorius Stedim Biotech (DIM:FP) (OTC: SDMHF) to EUR240.00 (from EUR210.00) while maintaining a Overweight rating. http://www.streetinsider.com/Intl+Ratings/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Raised+to+EUR240+at+Barclays/27032457.html Tue, 08 Sep 2026 05:39:33 -0400 SDMHF http://www.streetinsider.com/Intl+Ratings/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Raised+to+EUR240+at+Barclays/27032457.html Barclays analyst Charles Pitman raised the price target on Sartorius Stedim Biotech (DIM:FP) (OTC: SDMHF) to EUR240.00 (from EUR210.00) while maintaining a Overweight rating. http://www.streetinsider.com/Intl+Ratings/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Raised+to+EUR240+at+Barclays/27032457.html Tue, 08 Sep 2026 05:39:33 -0400 SDMHF http://www.streetinsider.com/Analyst+PT+Change/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Raised+to+EUR240+at+Barclays/27032457.html Barclays analyst Charles Pitman raised the price target on Sartorius Stedim Biotech (DIM:FP) (OTC: SDMHF) to EUR240.00 (from EUR210.00) while maintaining a Overweight rating. http://www.streetinsider.com/Analyst+PT+Change/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Raised+to+EUR240+at+Barclays/27032457.html Tue, 08 Sep 2026 05:39:33 -0400 SDMHF http://www.streetinsider.com/Analyst+PT+Change/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Raised+to+EUR240+at+Barclays/27032457.html Barclays analyst Charles Pitman raised the price target on Sartorius Stedim Biotech (DIM:FP) (OTC: SDMHF) to EUR240.00 (from EUR210.00) while maintaining a Overweight rating. http://www.streetinsider.com/Analyst+PT+Change/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Raised+to+EUR240+at+Barclays/27032457.html Tue, 08 Sep 2026 05:39:33 -0400 SDMHF http://www.streetinsider.com/Intl+Ratings/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Raised+to+EUR240+at+HSBC/27007473.html HSBC analyst Shubhangi Gupta raised the price target on Sartorius Stedim Biotech (DIM:FP) (OTC: SDMHF) to EUR240.00 (from EUR230.00) while maintaining a Buy rating. http://www.streetinsider.com/Intl+Ratings/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Raised+to+EUR240+at+HSBC/27007473.html Tue, 01 Sep 2026 02:15:55 -0400 SDMHF http://www.streetinsider.com/Intl+Ratings/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Raised+to+EUR240+at+HSBC/27007473.html HSBC analyst Shubhangi Gupta raised the price target on Sartorius Stedim Biotech (DIM:FP) (OTC: SDMHF) to EUR240.00 (from EUR230.00) while maintaining a Buy rating. http://www.streetinsider.com/Intl+Ratings/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Raised+to+EUR240+at+HSBC/27007473.html Tue, 01 Sep 2026 02:15:55 -0400 SDMHF http://www.streetinsider.com/Analyst+PT+Change/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Raised+to+EUR240+at+HSBC/27007473.html HSBC analyst Shubhangi Gupta raised the price target on Sartorius Stedim Biotech (DIM:FP) (OTC: SDMHF) to EUR240.00 (from EUR230.00) while maintaining a Buy rating. http://www.streetinsider.com/Analyst+PT+Change/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Raised+to+EUR240+at+HSBC/27007473.html Tue, 01 Sep 2026 02:15:55 -0400 SDMHF http://www.streetinsider.com/Analyst+PT+Change/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Raised+to+EUR240+at+HSBC/27007473.html HSBC analyst Shubhangi Gupta raised the price target on Sartorius Stedim Biotech (DIM:FP) (OTC: SDMHF) to EUR240.00 (from EUR230.00) while maintaining a Buy rating. http://www.streetinsider.com/Analyst+PT+Change/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Raised+to+EUR240+at+HSBC/27007473.html Tue, 01 Sep 2026 02:15:55 -0400 SDMHF http://www.streetinsider.com/Intl+Ratings/UBS+Upgrades+Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+to+Buy/26951882.html <p>UBS analyst Matthew Weston upgraded Sartorius Stedim Biotech (DIM:FP) (OTC: SDMHF) from Neutral to Buy with a price target of EUR260.00 (from EUR220.00).</p><p>The analyst comments: “Sartorius Stedim is well-positioned for accelerating growth in 2027 and into the mid term. We forecast strong underlying demand in bioprocess consumables, driven by increased pharmaceutical use with aging population, the high proportion of biologic assets in the biopharma R&D pipelines and the likely uplift in production volumes from blockbuster biosimilar launches 2028-2032E. In addition, the onshoring of US biomanufacturing should drive a bolus of Bioprocess equipment demand from 2H27E. We see significant opportunities for http://www.streetinsider.com/Intl+Ratings/UBS+Upgrades+Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+to+Buy/26951882.html Thu, 20 Aug 2026 02:47:57 -0400 SDMHF http://www.streetinsider.com/Intl+Ratings/UBS+Upgrades+Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+to+Buy/26951882.html <p>UBS analyst Matthew Weston upgraded Sartorius Stedim Biotech (DIM:FP) (OTC: SDMHF) from Neutral to Buy with a price target of EUR260.00 (from EUR220.00).</p><p>The analyst comments: “Sartorius Stedim is well-positioned for accelerating growth in 2027 and into the mid term. We forecast strong underlying demand in bioprocess consumables, driven by increased pharmaceutical use with aging population, the high proportion of biologic assets in the biopharma R&D pipelines and the likely uplift in production volumes from blockbuster biosimilar launches 2028-2032E. In addition, the onshoring of US biomanufacturing should drive a bolus of Bioprocess equipment demand from 2H27E. We see significant opportunities for http://www.streetinsider.com/Intl+Ratings/UBS+Upgrades+Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+to+Buy/26951882.html Thu, 20 Aug 2026 02:47:57 -0400 SDMHF http://www.streetinsider.com/Upgrades/UBS+Upgrades+Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+to+Buy/26951882.html <p>UBS analyst Matthew Weston upgraded Sartorius Stedim Biotech (DIM:FP) (OTC: SDMHF) from Neutral to Buy with a price target of EUR260.00 (from EUR220.00).</p><p>The analyst comments: “Sartorius Stedim is well-positioned for accelerating growth in 2027 and into the mid term. We forecast strong underlying demand in bioprocess consumables, driven by increased pharmaceutical use with aging population, the high proportion of biologic assets in the biopharma R&D pipelines and the likely uplift in production volumes from blockbuster biosimilar launches 2028-2032E. In addition, the onshoring of US biomanufacturing should drive a bolus of Bioprocess equipment demand from 2H27E. We see significant opportunities for http://www.streetinsider.com/Upgrades/UBS+Upgrades+Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+to+Buy/26951882.html Thu, 20 Aug 2026 02:47:57 -0400 SDMHF http://www.streetinsider.com/Upgrades/UBS+Upgrades+Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+to+Buy/26951882.html <p>UBS analyst Matthew Weston upgraded Sartorius Stedim Biotech (DIM:FP) (OTC: SDMHF) from Neutral to Buy with a price target of EUR260.00 (from EUR220.00).</p><p>The analyst comments: “Sartorius Stedim is well-positioned for accelerating growth in 2027 and into the mid term. We forecast strong underlying demand in bioprocess consumables, driven by increased pharmaceutical use with aging population, the high proportion of biologic assets in the biopharma R&D pipelines and the likely uplift in production volumes from blockbuster biosimilar launches 2028-2032E. In addition, the onshoring of US biomanufacturing should drive a bolus of Bioprocess equipment demand from 2H27E. We see significant opportunities for http://www.streetinsider.com/Upgrades/UBS+Upgrades+Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+to+Buy/26951882.html Thu, 20 Aug 2026 02:47:57 -0400 SDMHF http://www.streetinsider.com/Analyst+Comments/UBS+Upgrades+Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+to+Buy/26951882.html <p>UBS analyst Matthew Weston upgraded Sartorius Stedim Biotech (DIM:FP) (OTC: SDMHF) from Neutral to Buy with a price target of EUR260.00 (from EUR220.00).</p><p>The analyst comments: “Sartorius Stedim is well-positioned for accelerating growth in 2027 and into the mid term. We forecast strong underlying demand in bioprocess consumables, driven by increased pharmaceutical use with aging population, the high proportion of biologic assets in the biopharma R&D pipelines and the likely uplift in production volumes from blockbuster biosimilar launches 2028-2032E. In addition, the onshoring of US biomanufacturing should drive a bolus of Bioprocess equipment demand from 2H27E. We see significant opportunities for http://www.streetinsider.com/Analyst+Comments/UBS+Upgrades+Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+to+Buy/26951882.html Thu, 20 Aug 2026 02:47:57 -0400 SDMHF http://www.streetinsider.com/Analyst+Comments/UBS+Upgrades+Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+to+Buy/26951882.html <p>UBS analyst Matthew Weston upgraded Sartorius Stedim Biotech (DIM:FP) (OTC: SDMHF) from Neutral to Buy with a price target of EUR260.00 (from EUR220.00).</p><p>The analyst comments: “Sartorius Stedim is well-positioned for accelerating growth in 2027 and into the mid term. We forecast strong underlying demand in bioprocess consumables, driven by increased pharmaceutical use with aging population, the high proportion of biologic assets in the biopharma R&D pipelines and the likely uplift in production volumes from blockbuster biosimilar launches 2028-2032E. In addition, the onshoring of US biomanufacturing should drive a bolus of Bioprocess equipment demand from 2H27E. We see significant opportunities for http://www.streetinsider.com/Analyst+Comments/UBS+Upgrades+Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+to+Buy/26951882.html Thu, 20 Aug 2026 02:47:57 -0400 SDMHF http://www.streetinsider.com/Intl+Ratings/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Lowered+to+EUR210+at+Barclays/26815146.html Barclays analyst Charles Pitman lowered the price target on Sartorius Stedim Biotech (DIM:FP) (OTC: SDMHF) to EUR210.00 (from EUR220.00) while maintaining a Overweight rating. http://www.streetinsider.com/Intl+Ratings/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Lowered+to+EUR210+at+Barclays/26815146.html Mon, 27 Jul 2026 04:43:37 -0400 SDMHF http://www.streetinsider.com/Intl+Ratings/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Lowered+to+EUR210+at+Barclays/26815146.html Barclays analyst Charles Pitman lowered the price target on Sartorius Stedim Biotech (DIM:FP) (OTC: SDMHF) to EUR210.00 (from EUR220.00) while maintaining a Overweight rating. http://www.streetinsider.com/Intl+Ratings/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Lowered+to+EUR210+at+Barclays/26815146.html Mon, 27 Jul 2026 04:43:37 -0400 SDMHF http://www.streetinsider.com/Analyst+PT+Change/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Lowered+to+EUR210+at+Barclays/26815146.html Barclays analyst Charles Pitman lowered the price target on Sartorius Stedim Biotech (DIM:FP) (OTC: SDMHF) to EUR210.00 (from EUR220.00) while maintaining a Overweight rating. http://www.streetinsider.com/Analyst+PT+Change/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Lowered+to+EUR210+at+Barclays/26815146.html Mon, 27 Jul 2026 04:43:37 -0400 SDMHF http://www.streetinsider.com/Analyst+PT+Change/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Lowered+to+EUR210+at+Barclays/26815146.html Barclays analyst Charles Pitman lowered the price target on Sartorius Stedim Biotech (DIM:FP) (OTC: SDMHF) to EUR210.00 (from EUR220.00) while maintaining a Overweight rating. http://www.streetinsider.com/Analyst+PT+Change/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Lowered+to+EUR210+at+Barclays/26815146.html Mon, 27 Jul 2026 04:43:37 -0400 SDMHF http://www.streetinsider.com/Intl+Ratings/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Lowered+to+EUR230+at+HSBC/26594519.html HSBC analyst Shubhangi Gupta lowered the price target on Sartorius Stedim Biotech (DIM:FP) (OTC: SDMHF) to EUR230.00 (from EUR233.00) while maintaining a Buy rating. http://www.streetinsider.com/Intl+Ratings/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Lowered+to+EUR230+at+HSBC/26594519.html Wed, 03 Jun 2026 05:13:02 -0400 SDMHF http://www.streetinsider.com/Intl+Ratings/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Lowered+to+EUR230+at+HSBC/26594519.html HSBC analyst Shubhangi Gupta lowered the price target on Sartorius Stedim Biotech (DIM:FP) (OTC: SDMHF) to EUR230.00 (from EUR233.00) while maintaining a Buy rating. http://www.streetinsider.com/Intl+Ratings/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Lowered+to+EUR230+at+HSBC/26594519.html Wed, 03 Jun 2026 05:13:02 -0400 SDMHF http://www.streetinsider.com/Analyst+PT+Change/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Lowered+to+EUR230+at+HSBC/26594519.html HSBC analyst Shubhangi Gupta lowered the price target on Sartorius Stedim Biotech (DIM:FP) (OTC: SDMHF) to EUR230.00 (from EUR233.00) while maintaining a Buy rating. http://www.streetinsider.com/Analyst+PT+Change/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Lowered+to+EUR230+at+HSBC/26594519.html Wed, 03 Jun 2026 05:13:02 -0400 SDMHF http://www.streetinsider.com/Analyst+PT+Change/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Lowered+to+EUR230+at+HSBC/26594519.html HSBC analyst Shubhangi Gupta lowered the price target on Sartorius Stedim Biotech (DIM:FP) (OTC: SDMHF) to EUR230.00 (from EUR233.00) while maintaining a Buy rating. http://www.streetinsider.com/Analyst+PT+Change/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Lowered+to+EUR230+at+HSBC/26594519.html Wed, 03 Jun 2026 05:13:02 -0400 SDMHF http://www.streetinsider.com/SEC+Filings/Form++F-6EF++++++Sartorius+Stedim+Biotech+++++++++++++++Filed+by%3A+BANK+OF+NEW+YORK++ADR+DIVISION/26351097.html si-local-file:///var/storage/secattach/20260422/26351097.html http://www.streetinsider.com/SEC+Filings/Form++F-6EF++++++Sartorius+Stedim+Biotech+++++++++++++++Filed+by%3A+BANK+OF+NEW+YORK++ADR+DIVISION/26351097.html Wed, 22 Apr 2026 16:00:00 -0400 DIM O.00324940 SDMHF http://www.streetinsider.com/SEC+Filings/Form++F-6EF++++++Sartorius+Stedim+Biotech+++++++++++++++Filed+by%3A+BANK+OF+NEW+YORK++ADR+DIVISION/26351097.html si-local-file:///var/storage/secattach/20260422/26351097.html http://www.streetinsider.com/SEC+Filings/Form++F-6EF++++++Sartorius+Stedim+Biotech+++++++++++++++Filed+by%3A+BANK+OF+NEW+YORK++ADR+DIVISION/26351097.html Wed, 22 Apr 2026 16:00:00 -0400 DIM O.00324940 SDMHF http://www.streetinsider.com/SEC+Filings/Form++F-6EF++++++Sartorius+Stedim+Biotech+++++++++++++++Filed+by%3A+BANK+OF+NEW+YORK++ADR+DIVISION/26351097.html si-local-file:///var/storage/secattach/20260422/26351097.html http://www.streetinsider.com/SEC+Filings/Form++F-6EF++++++Sartorius+Stedim+Biotech+++++++++++++++Filed+by%3A+BANK+OF+NEW+YORK++ADR+DIVISION/26351097.html Wed, 22 Apr 2026 16:00:00 -0400 DIM O.00324940 SDMHF